American Academy of Allergy, Asthma & Immunology/American College of Allergy, Asthma & Immunology Omalizumab-Associated Anaphylaxis Joint Task Force follow-up report

被引:104
作者
Cox, Linda [1 ]
Lieberman, Phillip [1 ]
Wallace, Dana [1 ]
Simons, F. Estelle R. [2 ]
Finegold, Ira [3 ]
Platts-Mills, Thomas [4 ,5 ]
Schwartz, Lawrence [6 ]
机构
[1] Nova SE Univ, Dept Med, Davie, FL USA
[2] Univ Manitoba, Dept Pediat & Child Hlth, Dept Immunol, Fac Med, Winnipeg, MB, Canada
[3] St Lukes Roosevelt Hosp, Dept Allergy, RA Cooke Inst Allergy, New York, NY USA
[4] Univ Virginia, Dept Internal Med, Charlottesville, VA USA
[5] Univ Virginia, Dept Microbiol, Div Allergy & Clin Immunol, Charlottesville, VA 22908 USA
[6] Virginia Commonwealth Univ, Dept Med, Div Rheumatol Allergy & Immunol, Richmond, VA 23298 USA
关键词
D O I
10.1016/j.jaci.2011.04.010
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:210 / 212
页数:3
相关论文
共 6 条
[1]   Delayed allergic reactions to omalizumab: Are patients reporting all cases? [J].
Barry, Peter J. ;
O'Mahony, Ann ;
Finnegan, Collette ;
O'Connor, Terence M. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (03) :785-786
[2]   American Academy of Allergy, Asthma & Immunology/American College of Allergy, Asthma and Immunology joint task force report on omalizumab-associated anaphylaxis [J].
Cox, Linda ;
Platts-Mills, Thomas A. E. ;
Finegold, Ira ;
Schwartz, Lawrence B. ;
Simons, F. Estelle R. ;
Wallace, Dana V. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (06) :1373-1377
[3]   THE SAFETY AND INTERPRETABILITY OF SKIN TESTS WITH OMALIZUMAB [J].
Lieberman, Phillip ;
Rahmaoui, Abdelkader ;
Wong, Dennis A. .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2010, 105 (06) :493-495
[4]   Omalizumab-associated anaphylactic reactions reported between January 2007 and June 2008 [J].
Lin, Robert Y. ;
Rodriguez-Baez, Gerson ;
Bhargave, Geeta A. .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2009, 103 (05) :442-445
[5]  
Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303
[6]  
*US FDA, 2011, US FOOD DRUG ADM APP